13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0000884300
Total reported value
$127.2M
$127.2M
83 檔
26.1%
According to the latest 13F quarterly dataset, Perkins Capital Management Inc managed an equity portfolio of $127.2M at the end of Q3 2025, spanning 83 distinct U.S. exchange-listed positions.
In Q3 2025, Perkins Capital Management Inc adopted a defensive or profit-taking posture, trimming 25 positions and completely liquidating 7 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NTRA | Natera Inc | Stock-Healthcare | 6.36% | +0.37% | -1.97% | |
| 2 | LLY | Eli Lilly & Co | Stock-Healthcare | 6.11% | +0.58% | -4.52% | |
| 3 | ✓ | Mdxhealth SA | Stock-Other | 5.75% | -2.72% | -1.23% | |
| 4 | MSFT | Microsoft CORP | Stock-Tech | 5.59% | -0.68% | -0.33% | |
| 5 | IDXX | Idexx Laboratories Inc | Stock-Healthcare | 5.46% | -1.09% | — | |
| 6 | AXGN | Axogen Inc | Stock-Other | 3.71% | +0.13% | -1.12% | |
| 7 | SKYT | Skywater Technology Inc | Stock-Other | 2.80% | -0.35% | +86.36% | |
| 8 | AMD | Advanced Micro Devices | Stock-Tech | 2.62% | +3.39% | -4.66% | |
| 9 | ABT | Abbott Laboratories | Stock-Healthcare | 2.54% | -0.54% | -0.85% | |
| 10 | MGNI | Magnite Inc | Stock-Other | 2.52% | +0.14% | -2.85% | |
| 11 | VCYT | Veracyte Inc | Stock-Other | 2.41% | +0.50% | -2.77% | |
| 12 | LMAT | Lemaitre Vascular Inc | Stock-Other | 2.35% | -0.73% | -0.81% | |
| 13 | BLZE | Backblaze Inc-a | Stock-Other | 2.29% | +2.75% | -1.93% | |
| 14 | ATEC | Alphatec Holdings Inc | Stock-Other | 2.22% | -0.56% | -3.61% | |
| 15 | APPS | Digital Turbine Inc | Stock-Other | 2.18% | — | -1.66% | |
| 16 | BKSY | Blacksky Technology Inc | Stock-Other | 2.11% | -0.05% | -2.26% | |
| 17 | INUV | Inuvo Inc | Stock-Other | 2.08% | -0.62% | -3.50% | |
| 18 | OOMA | Ooma Inc | Stock-Other | 1.98% | +0.21% | -1.75% | |
| 19 | CYRX | Cryoport Inc | Stock-Other | 1.73% | +0.89% | +21.89% | |
| 20 | BFLY | Butterfly Network Inc | Stock-Other | 1.57% | +2.23% | +213.04% | |
| 21 | INGN | Inogen Inc | Stock-Other | 1.46% | -1.16% | EXIT | |
| 22 | PSNL | Personalis Inc | Stock-Other | 1.45% | +1.09% | — | |
| 23 | ONDS | Ondas Inc | Stock-Tech | 1.39% | -0.40% | -72.48% | |
| 24 | CIEN | Ciena CORP | Stock-Tech | 1.21% | -0.80% | -2.59% | |
| 25 | ABBV | Abbvie Inc | Stock-Healthcare | 1.19% | -0.04% | -0.85% | |
| 26 | ✓ | Stock-Other | 1.15% | -1.07% | EXIT | ||
| 27 | TELA | Tela Bio Inc | Stock-Other | 1.10% | -0.01% | -4.79% | |
| 28 | QUIK | Quicklogic CORP | Stock-Other | 1.09% | +1.35% | +0.99% | |
| 29 | USIO | Usio Inc | Stock-Other | 1.07% | +0.62% | -13.46% | |
| 30 | AAPL | Apple Inc | Stock-Tech | 1.04% | -0.03% | — | |
| 31 | PERI | Perion Network Ltd. | Stock-Other | 1.04% | -0.21% | -4.45% | |
| 32 | ZETA | Zeta Global Holdings Corp-a | Stock-Tech | 1.01% | +0.04% | — | |
| 33 | LUCD | Lucid Diagnostics Inc | Stock-Other | 1.00% | -0.26% | — | |
| 34 | CXDO | Crexendo Inc | Stock-Other | 0.97% | +0.12% | -1.03% | |
| 35 | NEO | Neogenomics Inc | Stock-Healthcare | 0.93% | +0.34% | -18.52% | |
| 36 | ELUT | Elutia Inc | Stock-Other | 0.89% | -0.44% | -1.95% | |
| 37 | PFE | Pfizer Inc | Stock-Healthcare | 0.88% | -0.30% | -3.58% | |
| 38 | ATRC | Atricure Inc | Stock-Other | 0.86% | -0.31% | -4.65% | |
| 39 | GILD | Gilead Sciences Inc | Stock-Healthcare | 0.81% | -0.22% | -0.80% | |
| 40 | T | At&t Inc | Stock-Comm Services | 0.71% | -0.17% | -6.59% | |
| 41 | ANIP | Ani Pharmaceuticals Inc | Stock-Other | 0.68% | -0.57% | EXIT | |
| 42 | OPRX | Optimizerx CORP | Stock-Other | 0.68% | -0.02% | -3.84% | |
| 43 | CDXS | Codexis Inc | Stock-Other | 0.66% | +0.13% | -1.38% | |
| 44 | LFVN | Lifevantage CORP | Stock-Other | 0.65% | +0.06% | — | |
| 45 | MRK | Merck & Co. Inc. | Stock-Healthcare | 0.65% | -0.11% | — | |
| 46 | HAIN | Hain Celestial Group Inc | Stock-Other | 0.62% | — | +256.36% | |
| 47 | CSTL | Castle Biosciences Inc | Stock-Other | 0.56% | -0.05% | +0.54% | |
| 48 | USB | US Bancorp | Stock-Financials | 0.55% | -0.02% | -1.15% | |
| 49 | DAWNGBX | Day One Biopharmaceuticals I | Stock-Other | 0.51% | — | — | |
| 50 | VTRS | Viatris Inc | Stock-Healthcare | 0.50% | -0.03% | +1.44% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Mdxhealth SA | +4% | -1.23% | Add |
| 2 | SKYT | Skywater Technology Inc | +2% | +86.36% | Add |
| 3 | IDXX | Idexx Laboratories Inc | +1.2% | — | Unchanged |
| 4 | BKSY | Blacksky Technology Inc | +1.1% | -2.26% | Trim |
| 5 | APPS | Digital Turbine Inc | +1.1% | -1.66% | Trim |
| 6 | BFLY | Butterfly Network Inc | +0.9% | +213.04% | Add |
| 7 | BLZE | Backblaze Inc-a | +0.8% | -1.93% | Trim |
| 8 | MGNI | Magnite Inc | +0.8% | -2.85% | Trim |
| 9 | CYRX | Cryoport Inc | +0.7% | +21.89% | Add |
| 10 | MSFT | Microsoft CORP | +0.7% | -0.33% | Trim |
| 11 | PERI | Perion Network Ltd. | +0.6% | -4.45% | Add |
| 12 | PSNL | Personalis Inc | +0.5% | — | Trim |
| 13 | AMD | Advanced Micro Devices | +0.4% | -4.66% | Trim |
| 14 | CIEN | Ciena CORP | +0.3% | -2.59% | Trim |
| 15 | ATEC | Alphatec Holdings Inc | +0.3% | -3.61% | Trim |
| 16 | DYAI | Dyadic International Inc | +0.3% | +627.38% | Add |
| 17 | OPRX | Optimizerx CORP | +0.3% | -3.84% | Trim |
| 18 | CELC | Celcuity Inc | +0.2% | -32.48% | Trim |
| 19 | CXDO | Crexendo Inc | +0.1% | -1.03% | Trim |
| 20 | ANIP | Ani Pharmaceuticals Inc | +0.1% | — | Unchanged |
| 21 | GIS | General Mills Inc | -0.3% | -1.40% | Trim |
| 22 | MRK | Merck & Co. Inc. | -0.3% | — | Trim |
| 23 | FAST | Fastenal Co | -0.4% | — | Trim |
| 24 | GILD | Gilead Sciences Inc | -0.4% | -0.80% | Trim |
| 25 | USIO | Usio Inc | -0.5% | -13.46% | Trim |
| 26 | BMY | Bristol-myers Squibb Co | -0.5% | -19.18% | Trim |
| 27 | LFVN | Lifevantage CORP | -0.5% | — | Unchanged |
| 28 | OOMA | Ooma Inc | -0.7% | -1.75% | Trim |
| 29 | NEO | Neogenomics Inc | -0.9% | -18.52% | Trim |
| 30 | VCEL | Vericel CORP | -0.9% | -53.07% | Trim |
| 31 | AXGN | Axogen Inc | -1.2% | -1.12% | Trim |
| 32 | XGN | Exagen Inc | -1.4% | -91.34% | Trim |
| 33 | ELUT | Elutia Inc | -2.1% | -1.95% | Trim |
| 34 | LLY | Eli Lilly & Co | -2.4% | -4.52% | Trim |
| 35 | INUVGBP | Inuvo Inc | — | EXIT | Sold out |
| 36 | INUV | Inuvo Inc | — | NEW | New buy |
| 37 | UTE0 | Cantaloupe Inc | — | EXIT | Sold out |
| 38 | INGN | Inogen Inc | — | NEW | New buy |
| 39 | ONDS | Ondas Inc | — | NEW | New buy |
| 40 | ✓ | — | NEW | New buy | |
| 41 | ZETA | Zeta Global Holdings Corp-a | — | NEW | New buy |
| 42 | LUCD | Lucid Diagnostics Inc | — | NEW | New buy |
| 43 | VFF | Village Farms International | — | EXIT | Sold out |
| 44 | ✓ | Biodesix Inc | — | EXIT | Sold out |
| 45 | DAWNGBX | Day One Biopharmaceuticals I | — | NEW | New buy |
| 46 | SERA | Sera Prognostics Inc-a | — | EXIT | Sold out |
| 47 | BDSX | Biodesix Inc | — | NEW | New buy |
| 48 | BAX | Baxter International Inc | — | EXIT | Sold out |
| 49 | ✓ | Myomo Inc Com New | — | EXIT | Sold out |
| 50 | VELO | Velo3d Inc | — | NEW | New buy |
According to official SEC Form 13F filings, Perkins Capital Management Inc reported a total U.S. public equity portfolio value of $127.2M across 83 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including NTRA, LLY, MDXHEALTH SA) accounted for 26.1% of total reported equity market value during Q3 2025.
Top New Position Initiated
INUV
市值: $2.4M
Top Position Liquidated / Trimmed
INUVGBP
前期市值: $2.5M
During Q3 2025, Perkins Capital Management Inc's top holdings by market value included NTRA (6.4%)、LLY (6.1%)、MDXHEALTH SA (5.8%). The largest single position, NTRA, represented 6.4% of total portfolio value.
In Q3 2025, Perkins Capital Management Inc made 47 total portfolio adjustments, initiating 9 new buys, adding to 6 positions, trimming 25 holdings, and fully liquidating 7 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.